NCT05334290View on ClinicalTrials.gov

Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

October 5, 2023

Study Completion Date

August 5, 2024

Conditions
Neuroendocrine Tumors
Trial Locations (1)

20132

RECRUITING

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

Massimo Falconi

OTHER

NCT05334290 - Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment | Biotech Hunter | Biotech Hunter